The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cryotherapy market was valued at US$ 292 Million in 2021.
We expect the global cryotherapy market to exhibit a CAGR of 6.25% during 2022-2027.
The growing adoption of cryotherapy for treating oncological, dermatological, and cardiological disorders as it promotes faster recovery, is currently driving the global cryotherapy market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cryotherapy treatment procedures to reduce the risk of coronavirus infection upon hospital visits or interaction with healthcare professionals or medical equipments.
Based on the product, the global cryotherapy market can be segmented into cryosurgery devices, localized cryotherapy devices, and cryochambers and cryosaunas. Currently, cryochambers and cryosaunas hold the majority of the total market share.
Based on the application, the global cryotherapy market has been divided into surgical applications, pain management, and recovery, health and beauty. Among these, pain management currently exhibits a clear dominance in the market.
Based on the end user, the global cryotherapy market can be categorized into hospitals and specialty clinics, cryotherapy centers, and spas and fitness centers. Currently, cryotherapy centers account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global cryotherapy market include Boston Scientific Corporation, Brymill Cryogenic Systems, CooperSurgical Inc., Cortex Technology, CryoConcepts LP, Erbe Elektromedizin GmbH, Kriosystem-Care Sp. z o.o., Medtronic plc, METRUM CRYOFLEX Sp. z o.o. Sp. k., Pacira BioSciences Inc., US Cryotherapy, and Zimmer MedizinSysteme GmbH.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at